Mediclinic International Share Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Mediclinic International stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View analyst ratings for Mediclinic International or view top-rated stocks.

Wall Street analysts have given Mediclinic International a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mediclinic International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Mediclinic International is scheduled to release its next quarterly earnings announcement on Wednesday, May 26th 2021.
View our earnings forecast for Mediclinic International.

Mediclinic International's stock was trading at GBX 335.70 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MDC stock has decreased by 7.1% and is now trading at GBX 311.79.
View which stocks have been most impacted by COVID-19.

Mediclinic International pays an annual dividend of GBX 0.03 per share and currently has a dividend yield of 3.12%.
View Mediclinic International's dividend history.

4 equities research analysts have issued 1-year price objectives for Mediclinic International's shares. Their forecasts range from GBX 260 to GBX 323. On average, they expect Mediclinic International's share price to reach GBX 301 in the next twelve months. This suggests that the stock has a possible downside of 3.5%.
View analysts' price targets for Mediclinic International or view top-rated stocks among Wall Street analysts.

Some companies that are related to Mediclinic International include RHÖN-KLINIKUM Aktiengesellschaft (RHK), Spire Healthcare Group (SPI), CareTech (CTH), Georgia Healthcare Group PLC (GHG.L) (GHG), CENTRIC HEALTH (CHH), Totally (TLY), Assure (IOM), Venn Life Sciences (VENN), Widecells Group (WDC), Agility Health (AHI), (PHGI) (PHGI), American Shared Hospital Services (AMS), BLVD Centers (CXV), Brain Resource (BRC) and Cambian Group (CMBN).
View all of MDC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of MDC stock can currently be purchased for approximately GBX 311.79.

Mediclinic International has a market capitalization of £2.30 billion and generates £2.98 billion in revenue each year.

Mediclinic International employs 32,291 workers across the globe.

The official website for Mediclinic International is www.mediclinic.com.

Mediclinic International is headquartered at 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom.

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600.